Clinical Trial Update: Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in healthy infants completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Pneumonia

Drugs mentioned

• PNEUMOSIL (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: PATH | Conditions: Pneumonia, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2019-09-11